Logo-apb
Adv Pharm Bull. 2018;8(4): 617-625. doi: 10.15171/apb.2018.070
PMID: 30607334        PMCID: PMC6311639

Research Article

Bio Pharmaceutics Classification System (BCS) Class IV Drug Nanoparticles: Quantum Leap to Improve Their Therapeutic Index

Sachin Kumar 1, Ramneek Kaur 1, Rashi Rajput 1, Manisha Singh 1 * ORCID

Cited by CrossRef: 10


1- Sousa F, Nascimento C, Ferreira D, Reis S, Costa P. Reviving the interest in the versatile drug nystatin: A multitude of strategies to increase its potential as an effective and safe antifungal agent. Advanced Drug Delivery Reviews. 2023;199:114969 [Crossref]
2- Lomba L, Polo A, Werner Á, Lafuente C, Giner B. Deep eutectic solvents based on sugars for oral applications. European Journal of Pharmaceutics and Biopharmaceutics. 2023;191:103 [Crossref]
3- Zettl M, Winter C, Mantanus J, Hadjittofis E, Rome S, Leitinger G, Hsiao W, Roblegg E, Pinto J, Spoerk M. Needles to Spheres: Evaluation of inkjet printing as a particle shape enhancement tool. European Journal of Pharmaceutics and Biopharmaceutics. 2023;184:92 [Crossref]
4- Memarvar D, Yaqoubi S, Hamishehkar H, Lam M, Nokhodchi A. Impact of grinding balls on the size reduction of Aprepitant in wet ball milling procedure. Pharmaceutical Development and Technology. 2024;29(4):353 [Crossref]
5- Chikukwa M, Walker R, Khamanga S. Formulation and Characterisation of a Combination Captopril and Hydrochlorothiazide Microparticulate Dosage Form. Pharmaceutics. 2020;12(8):712 [Crossref]
6- Patel R, Shah U, Patel G. Optimization of poly(Ε-caprolactone) based biodegradable in situ porous drug-eluting insert of BCS class II/IV drug for targeted application. International Journal of Polymeric Materials and Polymeric Biomaterials. 2024;73(10):885 [Crossref]
7- Gogikar S, Sen S, Daravath S, Aalhate M, Mahajan S, Ateeq M, Singh P, Dikundwar A. Bioanalytical method development and validation of docetaxel and carvacrol in mice plasma using LC-QqQ-MS/MS. Eur J Mass Spectrom (Chichester). 2024;30(5-6):235 [Crossref]
8- Gupta R, Chen Y, Xie H. In vitro dissolution considerations associated with nano drug delivery systems. WIREs Nanomed Nanobiotechnol. 2021;13(6) [Crossref]